|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Increased expression of androgen receptor(AR) and enzymes in- volved in androgen synthesis in metastatic prostate cancer- Targets for novel personalized therapies显示文摘 | Mitsiades N Schultz N Taylor B S | 2009 | J Clin Oncol [45th Annu Meet Am Soc Clin Oncol (AS- CO) (May 29 June 2 Orlando) 200912009，27，15： | 1 |
| 2 | A randomized phaseⅢ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin(FLO)versus fluorouracil,leucovorin and cisplatin(FLP)显示文摘 | AI-Batran S Hartmann J Probst S | 2006 | J Clin Onc Proc Am Soc Clin Oncol2006，24，： | 1 |
| 3 | Irinotecan combined with infusion 5-fluorouracil and folinic acid (folfiri) in patiens with metastatic gastric cancer resistant to cisplatin-containing chemotherapy显示文摘 | Fazio N Zampino G Nol F | 2004 | J Clin Onc Proc Am Soc Clin Oncol2004，22，： | 1 |
| 4 | Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy显示文摘 | Stephenson A J Scardino P T Eastham J A | 2005 | J Am Soc Clin Oncol2005，23，28： | 1 |
| 5 | phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC) (Abstract)显示文摘 | Jae J Giessinger S Khan M | 2007 | Proc Am Soc Clin Oncol J Clin Oncol2007，25，： | 1 |
| 6 | Phase I trial of SU011248, a novel tyrosine kinase inhibitor in advanced solid tumors 显示文摘 | Rosen L Mulay M Long J | 2003 | J Proc Am Soc Clin Oncol2003，22，1： | 1 |
| 7 | Capecitabine and docetaxel for advanced gastric cancer 显示文摘 | Thuss Patience PC Kretzschmar A Dogan Y | | J Clin Onc Proc Am Soc Clin Oncol 20(/60，24，18： | 1 |
| 8 | Pharmacokinetic and pharrnacodynamic evaluation of SU11248 in a phase Ⅰ clinical trial of patients (pts) with imatinib-resistant gastrointestinal stromal tumor (GIST) 显示文摘 | Manning WC Bello CL Deprimo SE | 2003 | J Proc Am Soc Clin Oncol2003，22，1： | 1 |
| 9 | Combination chemotherapies in advanced gastric cancer:An updated meta-analysis 显示文摘 | Wagner AD Grothe W Haerting J | 2006 | J Clin Onc Proc Am Soc Clin Oncol2006，24，18： | 1 |
| 10 | A randomized phase III trial in patients with advanced adenocareinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (Flo) versus fluorouracil,leucovorin and cisplalin(Flp)显示文摘 | AL-Batran S Hartmann J Probst S | 2006 | J Clin Onc Proc Am Soc Clin Oncol2006，24，： | 1 |
| 11 | A phase II study of capecitabine plus oxalplatin (XELOX) as first-line therapy for patient with advanced gastric cancer显示文摘 | Park Y Lee J Pyoo B | 2006 | J Clin Oncol Proc Am Soc Clin Oncol2006，24，18： | 1 |
| 12 | A phase II study of capecitabine plus oxaliplatin (XELOX) as firstline therapy for patients with advanced gastric cancer显示文摘 | Park Y Lee J Ryoo B | 2006 | J Clin Onc Proc Am Soc Clin Oncol2006，24，18： | 1 |
| 13 | Capecitabine and docetaxel for advanced gastric cancer显示文摘 | Thuss Patience PC Kretzschmar A Dogan Y | 2006 | J Clin Onc Proc Am Soc Clin Oncol2006，24，18： | 1 |
| 14 | Postresection CA19-9 predicts overall survival in patients with pancreatic eancer treated with adjuvant chemoradiation: a prospective validation by RTOG9704显示文摘 | Berger AC Gareia M Hoffman JP | 2008 | J Clin Oncol Off J Am Soc Clin Oneol2008，26，36： | 1 |
| 15 | Final resuits of a randomized controlled phase Ⅲ trial(TAX 325) comparing docetaxel(T) combined with cisplatin(C) and 5-flurouracil (F) to CF in patients (pts) with metastatic gastric adanocarcinoma (MGC)显示文摘 | Moiseyenko VM Ajaui JA Tjulandin SA | 2005 | J Clin Onc Proc Am Soc Clin Oncol2005，23，： | 1 |
| 16 | BREAK-MB:a phase Ⅱ study assessing overallintracranial response rate(OIRR) to dabrafenib (GSK2118436 ) in patient (pts) with B RAFV600E/K mutation-positive melanoma with brain metastases显示文摘 | Kirkwood JM Long GV Trefzer U | 2012 | Off J Am Soc Clin Oncol2012，30，5： | 1 |
| 17 | Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer 显示文摘 | Burzykowski T Buyse M Piccart-Gebhart M J | 2008 | J Clin Oncol : OffJ Am Soc Clinl Oncol2008，26，12： | 1 |
| 18 | Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer显示文摘 | ASCO | 1997 | J Am Soc Clin Oncol1997，15，12： | 1 |
| 19 | Final results of multicentre phase Ⅱ study of irinotecan (CPT),cisplatin (CIS),and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GE) adenocarcinoma显示文摘 | Shah M A Ramanathan R K Ilson D | 2006 | J Clin Onc Proc Am Soc Clin Oncol2006，24，18： | 1 |
| 20 | Breast cancer treatment guidelines in older women 显示文摘 | Giordano SH Hortobagyi GN Kau SW | 2005 | J Clin Oncol: OffJ Am Soc Clin Oncol2005，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员